Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
you never answer
Answered it already previously, just go back and read...
This is a Stock/Company Discussion Board, correct? All i'm doing is discussing the Stock, Filings and Claims this Co and some "Promoters" made as available to the public. Since we are all adults it should be a normal thing to discuss such things, controversial standpoints included. It should be part of every DD!
It's beyond me what something like this:
And I'm not going to pump for the current 1-2 tick flippers...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119213171
LOL, GL with that!
That's why CDEL has tons but only shows 10K right?
That's why you see T trades right?
That's why the TA got gagged right?
That's why the Co had to increase the A/S to 5 Billion shares...
GL Sir
It's called Dilution,
nothing wrong with CDEL he is just selling shares into the market.
Ups and here is your AH T-Trade
This is the FDA approved phase 2 trail
Why can't anybody deliver nor find a link to the FDA Documents or official IRB Reviews?
Usually it's not to hard to find, if they exist...
Written and published by OHResearch in 2012 !!
Here some more Details:
http://teamupagainstcancer.org/archives/4708
EDITOR’S Note:
Optimal Health Research, a U.S. Company, has begun an FDA approved Institutional Review Board (IRB00008666) to conduct a Controlled Clinical Trial to further determine the potential benefit of this compound (GenEpic™). GenEpic™ has augmented the original formula by including additional vitamins, herbs, and minerals to boost the immune system during the protocol. GenEpic™ is available to Health Care Professionals throughout the World that would like to include patients in this IRB.
For additional information and for a domestic contact regarding participating in a case study protocol, please contact Dr. Steven Osguthorpe, ND at 801-264-8561, or www.ohresearch.com
What Results? i don't see any officially reviewed Results besides the weird Presentation from the Company. NO other or official source for em.
Oh i forgot:
NNRX only provides that information to investors and to people who want the company to be successful.
I'll take that as a "there are no official IRB reviewed Results" available anywhere.
IRB reviewed Clinical Trail Results would be published to the public especially if they would show "The Cure for Cancer"...
in 2013 this Company released this PR:
DRAPER, Utah, Nov. 11, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to provide this update regarding the GenEpic™ prostate cancer human clinical study that is currently underway. Nutranomics has previously announced a non-binding Letter of Intent with Genesar Nutraceuticals, LLC ("Genesar") with the intent of completing a licencing agreement to market and distribute GenEpic™ globally.
"We are very pleased to report that our science and legal teams have recently been able to conduct a full due diligence review of the most recent progress and data from the current IRB reviewed GenEpic™ human clinical study being conducted at OH Research Group in Salt Lake City, Utah," stated Nutranomics' CEO Dr. Tracy K. Gibbs. "The one-year study is now in its 11th month and we are all very encouraged by the positive results. We look forward to the conclusion of the current study within the next 60 days and completing the planned acquisition of the GenEpic™ distribution rights."
The GenEpic™ human clinical study on prostate cancer treatment and recovery has been reviewed by an Institutional Review Board (IRB). The IRB reviews plans for all research involving human subjects. The Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) (part of the National Institutes of Health) set the guidelines and regulations governing human subjects research and IRBs.
If so, it shouldn't be a problem to provide a link to the IRB Results for those Trails.
New Sole Officer filed with the NVSOS
JAMES B FRACK
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=SypfzLHbFA5oFhsSceVnvQ%253d%253d&nt7=0
Estimated Completion Date December 2016
Since some here like to refer to those "Clinical Trial Results", or let's say to the questionable Presentation this Company is publishing on the Web, here the Link that clearly shows that this Study is STILL ONGOING and NO RESULTS have been posted yet -> https://clinicaltrials.gov/ct2/show/record/NCT01987999
From the GenEpic Webpage:
GenEpic™ Prostate Clinical Trial IRB Report
Prostate Clinical Trial Results at 12 Months and 30 Months – Conducted by Optimal Health Research, Salt Lake City, UT
Institutional Review Board Report??? What's the Name of the Institution that has reviewed it, why isn't it outlined as it should?
Actually it seems like Gibb's Buddy Steven Osguthorpe N.D. has filed for another Trail but it hasn't started yet, if it will ever...
https://clinicaltrials.gov/ct2/show/record/NCT02286778
The two Clinical Trails above are the ONLY Trails this "Optimal Health Research" Company was/is involved in
http://www.trialdetails.com/investigator/Steven+Osguthorpe
The two Testimonials , they use in their "Presentation", can be actually found here: http://teamupagainstcancer.org/archives/5257 and the second one only in a newsletter available at the same site http://teamupagainstcancer.org/download/newsletters/Mar-Apr%202013%20Team%20Up%20Newsletter.pdf
Last Entries there 2013, and way before this "Clinical Trail"!! Why...hmmmm
Check with the NVSOS...
Osceola Gold Inc, September 10 ·
Electrical is being finished at site to start bringing our processing equipment
It was a T trade, reported 3 minutes after the close.
http://ih.advfn.com/stock-market/USOTC/nutranomics-inc-NNRX/trades
Form T OTC/Pink trades reflect executions that occurred during regular market hours but were not reported during those hours.
Another week is passing by and still no boots on the ground...
Osceola Gold Inc. ?@osceolagoldinc Nov 11
This year we are expanding the pond. Hope to have boots on the ground next week.
They are trying to sell it for years already.
That's how the very first Promo for this Company started back in 2013 with a goal of $4.85 -> http://www.goodetrades.com/wp-content/uploads/2013/09/NNRX-2013-11-20.pdf!! LOL
Yes the last verified O/S was 533M shares per OTC, but that was one month ago, and since the TA is gagged only the Company knows the actual O/S.
Since they tried to R/S and added comments like this: The Company determined that the variable conversion price and the floor exceeding the authorized number of shares to every Debt Note at the time the 10K was filed (13th Nov), it's more than obvious that they ran out of shares. Explains the need for a R/S which highly likely got denied by FINRA due to Rule 6490 (3).
So the only option left was to increase the A/S which was done per the NVSOS Filing.
Since some here like to refer to those "Clinical Trial Results" this Company is publishing on the Web, here the Link that clearly shows that this Study is STILL ONGOING and NO RESULTS have been posted -> https://clinicaltrials.gov/ct2/show/record/NCT01987999
Estimated Completion Date December 2016
From the GenEpic Webpage:
GenEpic™ Prostate Clinical Trial IRB Report
Prostate Clinical Trial Results at 12 Months and 30 Months – Conducted by Optimal Health Research, Salt Lake City, UT
Institutional Review Board Report??? Who has reviewed it?
Actually it seems like Gibb's Buddy Steven Osguthorpe N.D. has filed for another Trail but it hasn't started yet, if it will ever...
https://clinicaltrials.gov/ct2/show/record/NCT02286778
The two above are the ONLY Trails this "Optimal Health Research" Company was/is involved in
http://www.trialdetails.com/investigator/Steven+Osguthorpe
The two Testimonials can be actually found on http://teamupagainstcancer.org/archives/5257 and the second one only in a newsletter available at the same site http://teamupagainstcancer.org/download/newsletters/Mar-Apr%202013%20Team%20Up%20Newsletter.pdf
Last Entries there 2013 !! Why...hmmmm
Oh and btw does anybody know if Mr.Gibbs has ever satisfied this Request from the SEC:
Directors and Executive Officers, page 31
8.
We note your disclosure on page 31 that Dr. Gibbs earned a PhD in
Pharmacognosy from KenchiKenkyu Gakkuin (Graduate School of Health Sciences) in Japan. We are unable to find any record of this institution.
In your supplemental response, please provide us with information that will help us confirm this institution’s existence and Dr. Gibbs’s PhD degree.
http://www.sec.gov/Archives/edgar/data/1451433/000000000014000375/filename1.pdf
Show me something better than NNRX
That's what the FILED NT shows...
Nice explanation for the late Filing:
Part IV(3) Explanation
It is anticipated that our net loss for the three months ended January 31, 2014, will be approximately $1,151,436, as compared to our net loss of $153,583 for the three months ended January 31, 2013, due primarily to an increase in general and administrative expenses, professional fees and salaries and wages, partially offset by an increase in gross profit.
Oh you assume all of em have been converted in full ,
GL with that!
NT-10Q just hit.
Company gained 15 Days for the Filing before the Truth will show up
No clue how you come up with the 134k number,
but IF they paid off any Notes i'm pretty sure they would have either PR'd it or filed it 4sure (Material Event!!).
Per the 10k only 2 Notes were fully converted at that time:
$78,500 face value, of which, $78,500 was converted
$53,000 face value, of which, $53,000 was converted
Since nothing like that has happened i think the number to go with is still ~$450-470k.
The Terms for each Note are slightly different but if 280M shares paid off just $37k of debt it's a long way to go.
This one for example:
$73,500 face value, of which, $3,667 was converted, issued on December 2, 2014, interest rate of 8%, matures on December 2, 2015
just 3.6k where converted.
Per todays Action and the usual Terms of these Notes, the Lender would be able to convert for the next couple days/weeks at ~ .0004 since the lowest pps today was .0008, right?
But there are more...
$63,000 face value, loan default resulted in loan balance 150% balance increase of $25,055, of which, $23,960 was converted
$59,000 face value, of which, $20,574 was converted
$65,000 face value, of which, $14,078 was converted
$33,000 face value, issued on March 17, 2015, interest rate of 8% maturing on December 19, 2015
$27,500 face value, issued on June 2, 2015, interest rate of 12% maturing on March 2, 2016
Again the next 10Q will the truth
GL
Believe what you want, the next 10Q will show the truth.
IF it would be the case they would have to file for it.
A the company, and b) the lender since they would own more than 5% and that's something these folks will avoid 4sure.
533M was the last verified O/S in early November, what is it now?
Did the Co ran out of shares for further conversion? very likely, imo.
Explains the increase of the A/S, no?
BTW in July with a pps of ~.0025 the estimated convertible shares were said to be ~850M have they hit yet, Debt was ~$520K?
37k went for 280M between Aug and Oct... nough said
Nov and Dec no numbers yet...
But here you have well known toxic lenders. almost every available one has a note here.
Nope, the Notes have matured, but it doesn't mean it was fully converted yet. Look at the converted Shares from KBM, JMJ, LG, Typenex and whatever other toxic lender and check the date when those Notes have matured.
They are sill converting shares for notes that were issued in April 2014, matures some 180 days later, so in Nov/Dec last year. And still not paid off.
But yes we'll get a little more info from the next 10Q.
the next Q will tell the truth.
Since the last 10K had conversions until October already included, only ~37k of those Notes got converted into ~280M shares , that leaves basically just NOV left.
JMHO
And it can be used to grow your Plants in the garden...
Metazyme - is a high energy metabolic plant stimulant. Metazyme is derived form cane molasses, seaweed extract, colloidal clay minerals, and yucca schidigera. Small amounts can stimulate the plant’s metabolism, increasing nutrient uptake and movement with the plant. Metazyme is a natural chelating agent; the amino-organic acid compounds may stimulate growth or in higher applications can shift the metabolic sync from vegetative to reproductive growth.
Seems to be pretty clear what the majority of these shares will be needed and used for -> Debt Conversion
Same Reason why the CO previously tried to R/S the O/S but leave the A/S unchanged.
Highly likely FINRA didn't approved by using per Rule 6940:
(3) FINRA has actual knowledge that the issuer, associated persons, officers, directors, transfer agent, legal adviser, promoters or other persons connected to the issuer or the SEA Rule 10b-17 Action or Other Company-Related Action are the subject of a pending, adjudicated or settled regulatory action or investigation by a federal, state or foreign regulatory agency, or a self-regulatory organization; or a civil or criminal action related to fraud or securities laws violations; (4) a state, federal or foreign authority or self-regulatory organization has provided information to FINRA, or FINRA otherwise has actual knowledge indicating that the issuer, associated persons, officers, directors, transfer agent, legal adviser, promoters or other persons connected with the issuer or the SEA Rule 10b-17 Action or Other Company-Related Action may be potentially involved in fraudulent activities related to the securities markets and/or pose a threat to public investors
Curt Kramer (Vis Vires now) settled with the SEC...
http://www.sec.gov/News/PressRelease/Detail/PressRelease/1370540410863
This might answer your Question:
Who issued the Metazyme trademark for Metagenics, Inc.?
On Thursday, October 24, 1996, a U.S. federal trademark registration was filed for METAZYME by Metagenics, Inc., Aliso Viejo, CA 92656. The USPTO has given the METAZYME trademark serial number of 75186976. The current federal status of this trademark filing is REGISTERED AND RENEWED. The correspondent listed for METAZYME is METAGENICS, INC. of 25 Enterprise, Suite 200, ALISO VIEJO CA 92656, . The METAZYME trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for METAZYME is nutritional supplements.
Known A/S Increase just appeared on the NVSOS
From 50M to 500M A/S
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=KBAYxVSdd481N3Xi%252bfhAeA%253d%253d&CorpName=CHINA+GINSENG+HOLDINGS%2c+INC.
As SEC Filer aren't they supposed to file a PRE 14C and a DEF 14C Filing prior to such NVSOS Filings?
Just wondering , since they did it for the R/S which probably related to a lot of Question from FINRA. Something that's happening pretty often now especially if known toxic Lenders are involved.
Just read the Filings for another Entity that was and still is trying to get a R/S and Company Name change approved (T..Y)
those shares camnot start hitting for 45 days if at all
You are aware of the Fact that many A/S increase Filings that show up on the NVSOS WepPage do not show an effective Date, correct?
Here some Examples:
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=dJa2lIZEGshASNJgMB9nCQ%253d%253d&CorpName=MONSTER+ARTS+INC
Now have a look at the related Filing with the OTC:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11057390
They even scanned the Doc that clearly shows an Effective Date, but not shown on the NVSOS Page.
Here another one:
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=QwDo6TBsuWMKUI9jehM%252fdw%253d%253d&CorpName=WILESS+CONTROLS+INC
It was published TODAY while the Filing Date shows 12/11/2015, NO Effective Date shown!
Here from the related Company Filing:
increase the number of authorized shares of common stock from five hundred million shares (500,000,000) to five billion shares
Paid off? Where are the filings for it?
Per the 10K the Company estimated the amount of convertible shares to (while the PPS was in the .002's.):
Potential Dilutive Shares as of July 31, 2015 are 873,942,968
File Date was 12/11/2015 per NVSOS
but it got published there on 12/12/2015
the company has not diluted via their conversions much
On August 6, 2015, KBM Worldwide converted $840 of additional principal related to its April 30, 2014 convertible note into 8,400,000 shares of the Company’s common stock.
On August 6, 2015, JMJ Financial converted $693 of additional principal related to its December 10, 2014 convertible note into 12,595,000 shares of the Company’s common stock.
On August 12, 2015, KBM Worldwide converted $815 of additional principal related to its April 30, 2014 convertible note into 13,583,333 shares of the Company’s common stock.
On August 18, 2015, Typenex Co-Investment, LLC converted $1,310 of additional principal related to its December 2, 2014 convertible note into 27,300,000 shares of the Company’s common stock.
On August 21, 2015, Evolution Capital Partners, LLC converted $862 of additional principal related to its December 10, 2014 convertible note into 15,680,000 shares of the Company’s common stock.
On August 27, 2015, JMJ Financial converted $905 of additional principal related to its December 10, 2014 convertible note into 16,460,000 shares of the Company’s common stock.
On August 27, 2015, Evolution Capital Partners, LLC converted $3,400 of additional principal related to its August 18, 2013 convertible note into 8,500,000 shares of the Company’s common stock.
On September 8, 2015, Typenex Co-Investment, LLC converted $1,699 of additional principal related to its December 2, 2014 convertible note into 35,400,000 shares of the Company’s common stock.
On October 5, 2015, KBM Worldwide converted $1,630 of additional principal related to its April 30, 2014 convertible note into 13,583,333 shares of the Company’s common stock.
On October 6, 2015, KBM Worldwide converted $700 of additional principal related to its April 30, 2014 convertible note into 5,833,333 shares of the Company’s common stock.
On October 6, 2015, KBM Worldwide converted $1,630 of additional principal related to its April 30, 2014 convertible note into 13,583,333 shares of the Company’s common stock.
On October 7, 2015, KBM Worldwide converted $2,725 of additional principal related to its April 30, 2014 convertible note into 19,464,286 shares of the Company’s common stock.
On October 9, 2015, KBM Worldwide converted $2,725 of additional principal related to its April 30, 2014 convertible note into 19,464,286 shares of the Company’s common stock.
On October 12, 2015, KBM Worldwide converted $2,920 of additional principal related to its April 30, 2014 convertible note into 19,466,667 shares of the Company’s common stock.
On October 15, 2015, KBM Worldwide converted $5,525 of additional principal related to its April 30, 2014 convertible note into 24,021,739 shares of the Company’s common stock.
On October 15, 2015, LG Capital Funding, LLC converted $3,053 of additional principal related to its December 2, 2014 convertible note into 13,157,887 shares of the Company’s common stock.
On October 20, 2015, KBM Worldwide converted $5,540 of additional principal related to its April 30, 2014 convertible note into 14,205,128 shares of the Company’s common stock.
It's filed with the NVSOS, so it is effective already...
Per the DEF 14C the Company was purely relying on the FINRA approval Date. Obviously FINRA never approved it.
Most likely the Reason for the A/S increase imo.
Per NVSOS it has happened !!
Where is the SEC Filing for it?
Just do some research on Curt, President of Vis Vires...
http://www.bloomberg.com/Research/stocks/private/person.asp?personId=286760008&privcapId=286590246&previousCapId=286590246&previousTitle=Vis%20Vires%20Group,%20Inc.
and this:
http://www.sec.gov/News/PressRelease/Detail/PressRelease/1370540410863
Ensure you check out Seth Kramer (his Brother) CEO of KBM too
http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapid=262392557
And yes the RS was never canceled per any of the Company Filings.
Check out the DEF 14C
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10702212
Looks like FINRA has denied the R/S
Maybe due to the Fact that Curt Kramer (via Vis Vires) is directly involved here.
Per the related DEF 14C, FINRA Approval was pending:
ACTIONS TO BE TAKEN
The Reverse Stock Split will become effective on the date that the Financial Industry Regulatory Authority (FINRA) approves and announces a reverse stock split, and the Preferred Stock Amendment will become effective on the date that we file an amendment to the Company's Articles of Incorporation (the " Amendment ") with the State of Nevada. We intend to file the Amendment with the State of Nevada promptly after the twentieth (20 th ) day following the date on which this Information Statement is mailed to the Stockholders, and intend to request that FINRA approve and announce the reverse stock split on the same date.
Authorized Shares . The Borrower covenants that during the period the conversion right exists, the Borrower will reserve from its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of this Note issued pursuant to the Purchase Agreement. The Borrower is required at all times to have authorized and reserved five times the number of shares that is actually issuable upon full conversion of the Note (based on the Conversion Price of the Notes in effect from time to time)(the “Reserved Amount”). The Reserved Amount shall be increased from time to time in accordance with the Borrower’s obligations hereunder. The Borrower represents that upon issuance, such shares will be duly and validly issued, fully paid and non-assessable. In addition, if the Borrower shall issue any securities or make any change to its capital structure which would change the number of shares of Common Stock into which the Notes shall be convertible at the then current Conversion Price, the Borrower shall at the same time make proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive rights, for conversion of the outstanding Notes. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock in accordance with the terms and conditions of this Note.
A/S increased to 5 Billion shares per NVSOS
Previous Stock Value:
Par Value Shares: 750,000,000 Value: $ 0.001
Par Value Shares: 25,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 775,000.00
New Stock Value:
Par Value Shares: 5,000,000,000 Value: $ 0.001
Par Value Shares: 25,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 5,025,000.00
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=1EPmkcHj8hF7PUSzDPnPsA%253d%253d&CorpName=NUTRANOMICS%2c+INC.
1:800 R/S filed with Finra
POMPANO BEACH, FL / December 11, 2015 / Baroma, Inc. (OTC: BRMA) Board of Directors announces that today the company filed documents with (FINRA) Financial Industry Regulatory Authority of a “Corporate Action” including a change in CUSIP, Name Change to GoooGreen, Inc. and 1 for 800 Reverse Split all to be effective January 15, 2016.
This action will result in a reduction the company's issued and outstanding common shares from approximately 302,500,000 common shares to approximately 380,000 common shares.
http://www.otcmarkets.com/stock/BRMA/news?id=121320
Name Change filed with NVSOS -> GOOOGREEN, INC.
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=tpDk77%252bj8UqED8wH0idrtQ%253d%253d&nt7=0